Former AstraZeneca exec charged with insider trading in Daiichi Sankyo’s licensing deal kdunleavy Tue, 05/31/2022 – 16:48 More: Former AstraZeneca exec charged with insider trading in Daiichi Sankyo's licensing deal Source: fierce
read moreSanofi and Regeneron’s pipeline-in-a drug Dupixent nabs priority review for yet another use zbecker Tue, 05/31/2022 – 15:35 More: Sanofi and Regeneron's pipeline-in-a drug Dupixent nabs priority review for yet another use Source: fierce
read moreASCO preview: How Gilead, Pfizer, AstraZeneca-Daiichi breast cancer data may—or may not—change treatment practice aliu Tue, 05/31/2022 – 12:03 More: ASCO preview: How Gilead, Pfizer, AstraZeneca-Daiichi breast cancer data may—or may not—change treatment practice Source: fierce
read moreAfter $500M IPO, HK inno.N enters exosome drug delivery via Ilias pact ntaylor Tue, 05/31/2022 – 10:34 More: After 0M IPO, HK inno.N enters exosome drug delivery via Ilias pact Source: fierce
read moreBavarian Nordic expects revenue boost after inking deals to supply monkeypox vaccine to more countries zbecker Tue, 05/31/2022 – 10:34 More: Bavarian Nordic expects revenue boost after inking deals to supply monkeypox vaccine to more countries Source: fierce
read more‘Act4Biosimilars’ will improve patient access and increase adoption in over 30 countries by 2030 More: Sandoz launches new global health inequalities initiative Source: News
read more© 1994 - 2025 B.M. Pharmaceuticals